title: Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea.
authors.forename: Ayako
authors.initials: A
authors.lastname: Mizota
authors.forename: Kohei
authors.initials: K
authors.lastname: Shitara
authors.forename: Takayuki
authors.initials: T
authors.lastname: Fukui
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001932:Brain Neoplasms / Q000150:complications / Q000473:pathology*; D004417:Dyspnea / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D018323:Hemangioendothelioma, Epithelioid / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000209:etiology; D008207:Lymphatic Metastasis; D008875:Middle Aged; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab